Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphology.
about
A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type IIA point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British familiesVariation in the vitreous phenotype of Stickler syndrome can be caused by different amino acid substitutions in the X position of the type II collagen Gly-X-Y triple helixCOL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDSMice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesisRegulation of corneal stroma extracellular matrix assemblyNon-enzymatic decomposition of collagen fibers by a biglycan antibody and a plausible mechanism for rheumatoid arthritisDevelopment of a functional skin matrix requires deposition of collagen V heterotrimersEffect of serum and insulin modulation on the organization and morphology of matrix synthesized by bovine corneal stromal cells.Cochlin and glaucoma: a mini-review.The functions of the multiproduct and rapidly evolving dec-1 eggshell gene are conserved between evolutionarily distant species of DrosophilaRegulation of the collagen phenotype expression of gamma-irradiated vascular smooth muscle cells by heparan mimetics (RGTA).Expression of type I and type V collagen mRNAs in the elasmoid scales of a teleost fish as revealed by in situ hybridization.Tendinopathy and tendon injury: the future.Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability?Col V siRNA engineered tenocytes for tendon tissue engineeringControl of heterotypic fibril formation by collagen V is determined by chain stoichiometry.Control of organization and function of muscle and tendon by thrombospondin-4.Basic fibroblast growth factor decreases type V/XI collagen expression in cultured bovine aortic smooth muscle cells.Proteomics reveal Cochlin deposits associated with glaucomatous trabecular meshwork.Response of donor and recipient cells after transplantation of cells to the ligament and tendon.Targeted deletion of collagen V in tendons and ligaments results in a classic Ehlers-Danlos syndrome joint phenotype.Collagen V is a dominant regulator of collagen fibrillogenesis: dysfunctional regulation of structure and function in a corneal-stroma-specific Col5a1-null mouse model.Cochlin in the eye: functional implications.Proteomic similarities in steroid responsiveness in normal and glaucomatous trabecular meshwork cellsMinor fibrillar collagens, variable regions alternative splicing, intrinsic disorder, and tyrosine sulfationCharacterization and expression of the mouse lumican gene.Changes in histoanatomical distribution of types I, III and V collagen promote adaptative remodeling in posterior tibial tendon rupture.Tissue engineering approaches for the construction of a completely autologous tendon substituteHuman pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host.Collagens and proteoglycans of the cornea: importance in transparency and visual disorders.Human recombinant alpha1(V) collagen chain. Homotrimeric assembly and subsequent processing.Response of human corneal fibroblasts on silk film surface patterns.Silk film biomaterials for cornea tissue engineering.Fibroblast growth factor-2 during postnatal development of the tracheal basement membrane zone.Type IIA procollagen: expression in developing chicken limb cartilage and human osteoarthritic articular cartilage.Temporal variation in the deposition of different types of collagen within a porous biomaterial implant.
P2860
Q22003991-D99B7289-D8D0-4A6D-950C-52F7CE83C8F6Q24318493-FA7E903D-9653-468D-9876-152BAF93EC50Q24534459-51890E2F-E602-42E0-9E1C-E5F4555B07EAQ24540243-68E9D2D6-3FF0-42D9-ADD6-8C9F18A860B0Q24683656-3BA8690A-F469-490B-B6F4-8FB2C2F7CD8FQ26830340-106A9B5C-1023-486C-9618-5E925F89EE3DQ28481473-1B88FA86-DD07-48C2-891C-4E04A0F029A1Q28593642-CB1CD547-0B58-4239-A145-38DB1E1434ECQ30492290-4AAA6D50-FEC7-4E71-BF2F-AF8E5913D871Q30499664-8A92DB66-DA3E-49D9-840C-E84792F092B1Q30772235-ACC29950-C303-492B-90E1-A1AA35B444E2Q30951973-C25F423F-430F-4D2D-B9FB-F08B7AC1B420Q30955541-C6A590C6-19E9-4569-B8DF-18131C7BA506Q33349910-9A388776-0206-4C02-A917-48D70402C07AQ33883998-4B56897A-905D-437B-B2AA-7030F17D173DQ33945381-11C7FAD8-89E5-49E5-A7B9-D142191A004FQ33952845-37BFE037-7EBA-4472-BCEF-38CC9B2A8E48Q34115854-48EA440A-D33B-4EAE-93B3-4155AA2D2863Q34453782-4A8F191E-3622-47D5-B3A8-3D663C9CFE50Q34698962-AA6F6692-FD54-47A2-8B4E-8FED3ED9632AQ34733225-4B15A803-A839-418A-A9E0-1B36D6AC1C19Q35568095-CB24475E-44DF-4F20-9929-DD9C1C63C3C3Q35630667-B55ED7D3-E2E5-4E4C-9B97-73D5784E8B0BQ36119792-5F3E68A6-4F9F-42A3-9702-E0A09ABDF2A5Q36145941-554C3B33-D1C2-4E86-85F7-7E9155422739Q36359165-A6DE471F-AE28-4A53-ADD2-7163D33B91A2Q36891818-3FF6867C-9FF0-401A-B3D6-5C3C31B38E87Q37147276-FC4ACF88-E11D-4644-B1F2-305E0E83D736Q37596999-023D5910-3D70-42B0-9920-5E548A870C1EQ38005762-5E47D6A8-1EB2-4F2F-8685-54E933AF0B07Q38552917-1585245B-C9BE-4F57-AFC3-4BD4A147ADC4Q41075269-AD221F1E-D172-46D9-B7BC-87D644FEFC4FQ42122890-42B11879-3074-48AE-957B-601344848008Q42176794-C349DF37-11EE-4DBF-906D-02C5228CB8E4Q42527080-19EECDE9-40B8-42AF-8CE9-5284E6B52D43Q43578617-692FF254-E4D8-4094-968B-2CF8D8A544D1Q52645412-40BC0FFD-1F52-4B23-9719-582386DC322E
P2860
Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphology.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Reduction of type V collagen u ...... al-specific fibril morphology.
@ast
Reduction of type V collagen u ...... al-specific fibril morphology.
@en
type
label
Reduction of type V collagen u ...... al-specific fibril morphology.
@ast
Reduction of type V collagen u ...... al-specific fibril morphology.
@en
prefLabel
Reduction of type V collagen u ...... al-specific fibril morphology.
@ast
Reduction of type V collagen u ...... al-specific fibril morphology.
@en
P2093
P2860
P356
P1476
Reduction of type V collagen u ...... al-specific fibril morphology.
@en
P2093
J K Marchant
T F Linsenmayer
P2860
P304
P356
10.1083/JCB.135.5.1415
P407
P577
1996-12-01T00:00:00Z